While an increase in BCR clone size was characteristic of class-switched BCRs in healthy repertoires, the malignant clones in CLL patients comprised primarily of IgD and IgM BCRs, constituting on average total of 83.6% of BCRs across individuals. This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.